EDWARDS LIFESCIENCES CORP

NYSE: EW (Edwards Lifesciences Corporatio)

最近更新时间: 27 Jan, 11:18PM

69.20

0.21 (0.30%)

前收盘价格 68.99
收盘价格 68.79
成交量 5,138,617
平均成交量 (3个月) 4,931,759
市值 40,814,157,824
市盈率 (P/E TTM) 26.72
预期市盈率 (P/E Forward) 29.94
价格/销量 (P/S) 6.92
股市价格/股市净资产 (P/B) 4.48
52周波幅
58.93 (-14%) — 96.12 (38%)
利润日期 4 Feb 2025 - 10 Feb 2025
营业毛利率 65.86%
营业利益率 (TTM) 29.11%
稀释每股收益 (EPS TTM) 2.59
季度收入增长率 (YOY) 8.90%
季度盈利增长率 (YOY) 697.80%
总债务/股东权益 (D/E MRQ) 7.35%
流动比率 (MRQ) 3.46
营业现金流 (OCF TTM) 806.40 M
杠杆自由现金流 (LFCF TTM) 1.79 B
资产报酬率 (ROA TTM) 10.65%
股东权益报酬率 (ROE TTM) 19.14%

市场趋势

短期 中期
行业 Medical Devices (US) 混合的 混合的
Medical Devices (全球的) 混合的 混合的
股票 Edwards Lifesciences Corporatio 看跌 看跌

AIStockmoo 评分

0.5
分析师共识 -0.5
内部交易活动 NA
价格波动 -1.0
技术平均移动指标 2.5
技术振荡指标 1.0
平均 0.50

相关股票

股票 市值 DY P/E(TTM) P/B
EW 41 B - 26.72 4.48
STE 21 B 1.01% 36.47 3.30
SNN 11 B 3.02% 35.51 2.15
SYK 150 B 0.82% 42.17 7.30
BSX 150 B - 84.08 7.33
PHG 25 B - - 2.02

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

部门 Healthcare
行业 Medical Devices
投资方式 Mid Core
内部持股比例 0.91%
机构持股比例 87.58%
52周波幅
58.93 (-14%) — 96.12 (38%)
目标价格波幅
60.00 (-13%) — 90.00 (30%)
90.00 (Stifel, 30.06%) 购买
90.00 (B of A Securities, 30.06%) 购买
90.00 (Goldman Sachs, 30.06%) 购买
85.00 (22.83%)
60.00 (Wolfe Research, -13.30%) 卖出
平均值 81.33 (17.53%)
总计 6 购买, 2 保留, 1 卖出
平均价格@调整类型 72.34
公司 日期 目标价格 调整类型 价格@调整类型
Stifel 30 Jan 2025 90.00 (30.06%) 购买 73.22
05 Dec 2024 75.00 (8.38%) 保留 72.43
Wolfe Research 16 Jan 2025 60.00 (-13.29%) 卖出 69.86
B of A Securities 16 Dec 2024 90.00 (30.06%) 购买 73.91
Citigroup 11 Dec 2024 83.00 (19.94%) 购买 73.81
Canaccord Genuity 05 Dec 2024 68.00 (-1.73%) 保留 72.43
Goldman Sachs 05 Dec 2024 90.00 (30.06%) 购买 72.43
RBC Capital 05 Dec 2024 85.00 (22.83%) 购买 72.43
27 Nov 2024 80.00 (15.61%) 购买 72.07
Truist Securities 05 Dec 2024 78.00 (12.72%) 保留 72.43
Barclays 02 Dec 2024 88.00 (27.17%) 购买 70.53
显示更多

该时间范围内无数据。

日期 类型 细节
04 Feb 2025 公告 Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
07 Jan 2025 公告 Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
13 Dec 2024 公告 Edwards Lifesciences (EW) Investors Alerted to Today's Lead Plaintiff Deadline in Class Action Lawsuit Over TAVM Platform Disclosures - Hagens Berman
13 Dec 2024 公告 Edwards Lifesciences (EW) Investors Alerted to Today's Lead Plaintiff Deadline in Class Action Lawsuit Over TAVM Platform Disclosures - Hagens Berman
09 Dec 2024 公告 EW DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit
09 Dec 2024 公告 EW DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit
07 Dec 2024 公告 Edwards Lifesciences Corporation Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
07 Dec 2024 公告 Edwards Lifesciences Corporation Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
06 Dec 2024 公告 EW DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Investors of Deadline and Encourages Investors with Losses to Contact the Firm
06 Dec 2024 公告 EW DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Investors of Deadline and Encourages Investors with Losses to Contact the Firm
05 Dec 2024 公告 Lead Plaintiff Deadline on December 13, 2024 for EW Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm
04 Dec 2024 公告 EW Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Deadline and Encourages Investors with Losses to Contact the Firm
04 Dec 2024 公告 Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
04 Dec 2024 公告 EW Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifescience Corporation (EW) Investors of Deadline and Encourages Investors with Losses to Contact the Firm
03 Dec 2024 公告 EW DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit
03 Dec 2024 公告 EW Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation (EW)
03 Dec 2024 公告 EW Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation (EW)
03 Dec 2024 公告 EW DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Edwards Lifesciences Corporation Securities Fraud Class Action Lawsuit
02 Dec 2024 公告 Investor Reminder (EW): Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Investors of December 13, 2024 Deadline
02 Dec 2024 公告 Investor Reminder (EW): Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Investors of December 13, 2024 Deadline
25 Nov 2024 公告 Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
14 Nov 2024 公告 Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion of Market Capitalization - Hagens Berman
10 Nov 2024 公告 EW INVESTOR ALERT: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票